Pharmaceuticals

USP Q&A: Dissolution, Disintegration and Drug Release Tests

Answers to Common Questions about USP Standards for Dissolution, Disintegration and Drug Release Tests

Dissolution, disintegration and drug release tests are important tools during the entire lifecycle of a drug product, from early development throughout its shelf life. USP’s Margareth Marques, Ph.D., provides answers to common questions and insight into standards and resources for these tests. 

Share

A <797> Rewritten with Patient Safety in Mind

Revised USP Standards for Compounding Sterile Preparations

Gigi Davidson, R.Ph., DICVP, Chair of USP's Compounding Expert Committee shares her thoughts and background information on proposed revisions to <797> Pharmaceutical Compounding—Sterile Preparations. Compounding practitioners are encouraged to view and share comments on the changes online.

Share

Updating Quality Standards for Nuclear Medicine and Radioactive Materials

Revised USP Quality Standards for Radioactive Articles

Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field. 

Share

Pages